Soleno Therapeutics, Inc. (SLNO) Free Cash Flow by Year
Soleno Therapeutics, Inc. generated $46.7M in free cash flow in fiscal year 2025. This represents an increase of 167.4% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $105.4M in free cash flow. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Soleno Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
SLNO Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
SLNO Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Soleno Therapeutics, Inc. financials
Frequently Asked Questions
What was Soleno Therapeutics, Inc.'s free cash flow in fiscal year 2025?
Soleno Therapeutics, Inc. generated $46.7M in free cash flow in fiscal year 2025.
How fast is Soleno Therapeutics, Inc.'s free cash flow growing?
Soleno Therapeutics, Inc. (SLNO) free cash flow rose by 167.4% year over year, from -$69.3M to $46.7M in fiscal year 2025.
What is Soleno Therapeutics, Inc.'s free cash flow over the last twelve months?
Soleno Therapeutics, Inc. (SLNO) reported $105.4M in free cash flow over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.
How has Soleno Therapeutics, Inc.'s free cash flow changed over the years?
Across the 13 fiscal years this page covers, Soleno Therapeutics, Inc. (SLNO) free cash flow went from -$886K in fiscal year 2013 to $46.7M in fiscal year 2025.
What was Soleno Therapeutics, Inc.'s free cash flow in the most recent quarter?
Soleno Therapeutics, Inc. (SLNO) reported $25.9M in free cash flow in Q1 2026. This represents an increase of 179.2% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Soleno Therapeutics, Inc. (SLNO) reported on that line in every period on record.